Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study.
J Cancer Res Clin Oncol
; 145(9): 2365-2373, 2019 Sep.
Article
in En
| MEDLINE
| ID: mdl-31280347
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Stomach Neoplasms
/
Weight Loss
/
Antineoplastic Combined Chemotherapy Protocols
/
Body Mass Index
/
Antibodies, Monoclonal
Type of study:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Cancer Res Clin Oncol
Year:
2019
Document type:
Article
Affiliation country:
Italy